April 8, 2014
Daiichi Sankyo President Joji Nakayama Daiichi Sankyo announced on April 7 that its Indian generic subsidiary Ranbaxy Laboratories will be merged into bigger Indian peer Sun Pharmaceutical Industries, but President Joji Nakayama says the share swap deal was not intended...read more